Tocqueville Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$303K | – | 742 |
|
|
2021
Q2 | $303K | Sell |
5,000
-10
| -0.2% | -$606 | ﹤0.01% | 634 |
|
|
2021
Q1 | $351K | Hold |
5,010
| – | – | 0.01% | 610 |
|
|
2020
Q4 | $300K | Sell |
5,010
-7
| -0.1% | -$419 | 0.01% | 623 |
|
|
2020
Q3 | $302K | Buy |
5,017
+17
| +0.3% | +$1.02K | 0.01% | 566 |
|
|
2020
Q2 | $262K | Buy |
+5,000
| New | +$262K | 0.01% | 587 |
|
|
2019
Q3 | – | Sell |
-4,900
| Closed | -$213K | – | 778 |
|
|
2019
Q2 | $213K | Sell |
4,900
-2,000
| -29% | -$86.9K | ﹤0.01% | 736 |
|
|
2019
Q1 | $263K | Sell |
6,900
-1,100
| -14% | -$41.9K | ﹤0.01% | 694 |
|
|
2018
Q4 | $344K | Sell |
8,000
-2,000
| -20% | -$86K | 0.01% | 610 |
|
|
2018
Q3 | $492K | Buy |
+10,000
| New | +$492K | 0.01% | 625 |
|
|
2016
Q4 | – | Sell |
-15,200
| Closed | -$520K | – | 842 |
|
|
2016
Q3 | $520K | Hold |
15,200
| – | – | 0.01% | 623 |
|
|
2016
Q2 | $513K | Hold |
15,200
| – | – | 0.01% | 630 |
|
|
2016
Q1 | $805K | Buy |
15,200
+3,300
| +28% | +$175K | 0.01% | 535 |
|
|
2015
Q4 | $914K | Buy |
+11,900
| New | +$914K | 0.01% | 559 |
|
|
2015
Q3 | – | Sell |
-12,750
| Closed | -$902K | – | 997 |
|
|
2015
Q2 | $902K | Sell |
12,750
-2,530
| -17% | -$179K | 0.01% | 589 |
|
|
2015
Q1 | $1.36M | Buy |
15,280
+1,780
| +13% | +$158K | 0.02% | 535 |
|
|
2014
Q4 | $1.2M | Buy |
+13,500
| New | +$1.2M | 0.01% | 548 |
|